A Next Generation TCR & Epitope Discovery Platform for the Development of Engineered TCR Therapies for Solid Tumours
Time: 11:00 am
day: Day 1 - Track A - Morning
Details:
- HuTCR, an innovative platform based on complex genetic engineering, leverages natural immune processes to generate TCRs with optimal affinity and high specificity
- Parallel epitope discovery and TCR identification to enhance throughput and reduce discovery lead time
- TK-8001, a CD8 TCR-T specific for a MAGE-A1 epitope presented on HLA-A*02-01
